These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20580029)

  • 1. Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status.
    Lamon-Fava S; Herrington DM; Horvath KV; Schaefer EJ; Asztalos BF
    Metabolism; 2010 Dec; 59(12):1794-800. PubMed ID: 20580029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women.
    Lamon-Fava S; Herrington DM; Reboussin DM; Sherman M; Horvath K; Schaefer EJ; Asztalos BF
    Atherosclerosis; 2009 Jul; 205(1):325-30. PubMed ID: 19155011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
    Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
    JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women.
    Lamon-Fava S; Herrington DM; Reboussin DM; Sherman M; Horvath KV; Cupples LA; White C; Demissie S; Schaefer EJ; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):575-9. PubMed ID: 18174456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins.
    Lamon-Fava S; Posfai B; Asztalos BF; Horvath KV; Dallal GE; Schaefer EJ
    Metabolism; 2003 Oct; 52(10):1330-6. PubMed ID: 14564686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
    Sutherland WH; Manning PJ; de Jong SA; Allum AR; Jones SD; Williams SM
    Metabolism; 2001 Mar; 50(3):319-24. PubMed ID: 11230785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins.
    Os I; Hofstad AE; Brekke M; Abdelnoor M; Nesheim BI; Jacobsen AF; Birkeland K; Larsen A; Midtbo K; Westheim A
    J Intern Med; 2000 Apr; 247(4):433-41. PubMed ID: 10792556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
    Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
    Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
    Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
    JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
    JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral combined hormone replacement therapy on plasma lipids and lipoproteins.
    Vadlamudi S; MacLean P; Israel RG; Marks RH; Hickey M; Otvos J; Barakat H
    Metabolism; 1998 Oct; 47(10):1222-6. PubMed ID: 9781625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women.
    Ko HS; Kim CJ; Ryu WS
    Korean J Intern Med; 2005 Mar; 20(1):33-9. PubMed ID: 15906951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.
    Lamon-Fava S; Asztalos BF; Howard TD; Reboussin DM; Horvath KV; Schaefer EJ; Herrington DM
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):169-75. PubMed ID: 19489872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse pressure and coronary atherosclerosis progression in postmenopausal women.
    Nair GV; Waters D; Rogers W; Kowalchuk GJ; Stuckey TD; Herrington DM
    Hypertension; 2005 Jan; 45(1):53-7. PubMed ID: 15545509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women.
    Man RY; Ting LK; Fan S; Lau MM; Siow YL; Chung YH; O K
    Mol Cell Biochem; 2001 Sep; 225(1-):129-34. PubMed ID: 11716354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women.
    Seed M
    Atheroscler Suppl; 2002 May; 3(1):53-63. PubMed ID: 12044587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sodium monofluorophosphate therapy on lipid and lipoprotein metabolism in postmenopausal women.
    Oral B; Ozbaşar D
    Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):180-4. PubMed ID: 12648865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.